Detalles de la búsqueda
1.
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Gynecol Oncol
; 172: 82-91, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001446
2.
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341461
3.
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(18): 3990-4002, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499569
4.
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
Mol Cancer Ther
; 20(11): 2240-2249, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34482288
5.
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 42020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33015525
Resultados
1 -
5
de 5
1
Próxima >
>>